Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

Similar articles for PubMed (Select 20670338)

1.

Routine diagnostic procedures of myelodysplastic syndromes: value of a structural blood cell parameter (NEUT-X) determined by the Sysmex XE-2100™.

Le Roux G, Vlad A, Eclache V, Malanquin C, Collon JF, Gantier M, Schillinger F, Peltier JY, Savin B, Letestu R, Baran-Marszak F, Fenaux P, Ajchenbaum-Cymbalista F.

Int J Lab Hematol. 2010 Dec;32(6 Pt 1):e237-43. doi: 10.1111/j.1751-553X.2010.01247.x.

PMID:
20670338
2.

The utility of the Sysmex XE-2100 analyzer's NEUT-X and NEUT-Y parameters for detecting neutrophil dysplasia in myelodysplastic syndromes.

Furundarena JR, Araiz M, Uranga M, Sainz MR, Agirre A, Trassorras M, Uresandi N, Montes MC, Argoitia N.

Int J Lab Hematol. 2010 Jun;32(3):360-6. doi: 10.1111/j.1751-553X.2009.01194.x. Epub 2009 Nov 10.

PMID:
19906272
3.
4.
5.

Usefulness of immature platelet fraction for the clinical evaluation of myelodysplastic syndromes.

Saigo K, Takenokuchi M, Imai J, Numata K, Isono S, Zenibayashi M, Tanioka H, Yoshioka T, Nishizawa A, Takada M, Nomura T, Kubota Y.

Lab Hematol. 2009;15(2):13-6. doi: 10.1532/LH96.09003.

PMID:
19561008
6.
7.

Pertinence of the Sysmex XE-5000™ parameters: rule of slide review in a context of 'normal' lymphocyte count (defined from control and mantle cell lymphoma blood specimens).

Chhuy J, Morel D, Goeddert G, Magaud JP, Felman P, Baseggio L.

Int J Lab Hematol. 2013 Oct;35(5):510-6. doi: 10.1111/ijlh.12042. Epub 2012 Dec 27.

PMID:
23279807
8.

Automated neutrophil morphology and its utility in the assessment of neutrophil dysplasia.

Miguel A, Orero M, Simon R, Collado R, Perez PL, Pacios A, Iglesias R, Martinez A, Carbonell F.

Lab Hematol. 2007;13(3):98-102.

PMID:
17984041
10.

Automated analysis of pleural fluid total and differential leukocyte counts with the Sysmex XE-2100.

de Jonge R, Brouwer R, van Rijn M, van Acker BA, Otten HJ, Lindemans J.

Clin Chem Lab Med. 2006;44(11):1367-71.

PMID:
17087651
11.

The myelodysplastic syndromes.

Nguyen PL.

Hematol Oncol Clin North Am. 2009 Aug;23(4):675-91. doi: 10.1016/j.hoc.2009.04.008. Review.

PMID:
19577164
12.

[Preliminary study of diagnosis of patients with myelodysplastic syndromes by routine laboratory parameters].

Li L, Nie L, Yu MH, Zheng YZ, Zhang Y, Xu ZF, Hao YS, Xiao ZJ.

Zhonghua Xue Ye Xue Za Zhi. 2008 Sep;29(9):623-8. Chinese.

PMID:
19175993
13.

The value of cell cultures for the diagnosis of mixed myelodysplastic/myeloproliferative disorders.

Del Cañizo MC, Brufau A, Mota A, Lopez N, Fernandez ME, Vallejo C, Hernandez JM, Garcia JL, San Miguel JF.

Haematologica. 1998 Jan;83(1):3-7.

14.

Reduction in multi-lineage and erythroid progenitors distinguishes myelodysplastic syndromes from non-malignant cytopenias.

Vercauteren SM, Bashashati A, Wu D, Brinkman RR, Eaves C, Eaves A, Karsan A.

Leuk Res. 2009 Dec;33(12):1636-42. doi: 10.1016/j.leukres.2009.03.019. Epub 2009 May 2.

PMID:
19414193
15.

Possibility of myelodysplastic syndromes screening using a complete blood automated cell count.

Rocco V, Maconi M, Gioia M, Silvestri MG, Tanca D, Catalano T, Avino D, Di Palma A, Rovetti A, Danise P.

Leuk Res. 2011 Dec;35(12):1623-7. doi: 10.1016/j.leukres.2011.06.015. Epub 2011 Jul 18.

PMID:
21764450
16.

Diagnostic flow cytometry for low-grade myelodysplastic syndromes.

Ogata K.

Hematol Oncol. 2008 Dec;26(4):193-8. doi: 10.1002/hon.857. Review.

PMID:
18412289
17.

[Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].

Schmitt-Graeff A, Mattern D, Köhler H, Hezel J, Lübbert M.

Pathologe. 2000 Jan;21(1):1-15. Review. German.

PMID:
10663664
18.

Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes.

Cherian S, Moore J, Bantly A, Vergilio JA, Klein P, Luger S, Bagg A.

Cytometry B Clin Cytom. 2005 Mar;64(1):9-17.

19.

Platelet mass has prognostic value in patients with myelodysplastic syndromes.

Bowles KM, Warner BA, Baglin TP.

Br J Haematol. 2006 Oct;135(2):198-200. Epub 2006 Aug 25.

PMID:
16939490
20.

Morphologic changes of neutrophils in myelodysplastic syndrome treated with recombinant human granulocyte colony-stimulating factor.

Toyama K, Ohyashiki K, Ohyashiki JH, Takaku F.

Jpn J Cancer Res. 1988 Jul;79(7):813-6.

PMID:
2459090
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk